BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11150025)

  • 1. Effects of anticoagulation on thrombopoietin release during endotoxemia.
    Jilma-Stohlawetz P; Folman CC; von dem Borne AE; Pernerstorfer T; Hollenstein U; Knechtelsdorfer M; Eichler HG; Jilma B
    J Lab Clin Med; 2001 Jan; 137(1):64-9. PubMed ID: 11150025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endotoxemia on thrombopoiesis in men.
    Stohlawetz P; Folman CC; von dem Borne AE; Pernerstorfer T; Eichler HG; Panzer S; Jilma B
    Thromb Haemost; 1999 Apr; 81(4):613-7. PubMed ID: 10235449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia.
    Derhaschnig U; Pernerstorfer T; Knechtelsdorfer M; Hollenstein U; Panzer S; Jilma B
    Crit Care Med; 2003 Apr; 31(4):1108-12. PubMed ID: 12682480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
    Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia.
    Mayr FB; Firbas C; Leitner JM; Spiel AO; Reiter RA; Beyer D; Meyer M; Wolff G; Jilma B
    Shock; 2008 Apr; 29(4):475-82. PubMed ID: 18598003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation at the onset of human endotoxemia is undetectable in vivo.
    Schrottmaier WC; Kral JB; Zeitlinger M; Salzmann M; Jilma B; Assinger A
    Platelets; 2016 Jul; 27(5):479-83. PubMed ID: 26764560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis.
    Cuccurullo A; Greco E; Lupia E; De Giuli P; Bosco O; Martin-Conte E; Spatola T; Turco E; Montrucchio G
    PLoS One; 2016; 11(3):e0151088. PubMed ID: 26963510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
    van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia.
    Schoergenhofer C; Schwameis M; Gelbenegger G; Buchtele N; Thaler B; Mussbacher M; Schabbauer G; Wojta J; Jilma-Stohlawetz P; Jilma B
    Thromb Haemost; 2018 Jul; 118(7):1176-1184. PubMed ID: 29864779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
    Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
    Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans.
    Hollenstein U; Homoncik M; Knöbl P; Pernerstorfer T; Graggaber J; Eichler HG; Handler S; Jilma B
    Clin Pharmacol Ther; 2002 May; 71(5):368-74. PubMed ID: 12011822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers.
    Schoergenhofer C; Buchtele N; Gelbenegger G; Derhaschnig U; Firbas C; Kovacevic KD; Schwameis M; Wohlfarth P; Rabitsch W; Jilma B
    Sci Rep; 2019 Jul; 9(1):11136. PubMed ID: 31366975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
    Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
    Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trial.
    Schoergenhofer C; Schwameis M; Hobl EL; Ay C; Key NS; Derhaschnig U; Jilma B; Spiel AO
    Clin Sci (Lond); 2016 Mar; 130(6):433-40. PubMed ID: 26554025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis.
    Wilson SJ; Connolly TM; Peters G; Ghosh A; Johnson M; Newby DE
    Cardiovasc Res; 2019 Mar; 115(3):669-677. PubMed ID: 30184110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.